Association of Polygenic-Based Breast Cancer Risk Prediction With Patient Management
Patients with ≥20% lifetime risk predicted by either CRS or TC were more likely to receive enhanced management compared with those who had <20% lifetime risk, suggesting that clinicians considered the CRS in BC risk management.
Authors
- Alexander Gutin (ORCID: https://orcid.org/0000-0002-6565-3729)
- Julia M. Certa (ORCID: https://orcid.org/0000-0002-0176-5019)
- Sarah Ratzel
- Elisha Hughes (ORCID: https://orcid.org/0000-0002-3145-3913)
- Jeffery S. Jasper
- Devika Chawla (ORCID: https://orcid.org/0000-0002-9727-6833)
- Allison W. Kurian (ORCID: https://orcid.org/0000-0002-6175-9470)
- Pamela Morin
- William Brady DeHart (ORCID: https://orcid.org/0000-0002-2542-2045)
- D. Claire Miller (ORCID: https://orcid.org/0000-0001-6144-8595)
- Laura Becker (ORCID: https://orcid.org/0000-0002-2023-7609)
- Katherine Johansen Taber
Institutions
- Palo Alto University (US)
- Optum (United States) (US)
- Myriad Genetics (US)
- Stanford University (US)
Publication Details
- Journal
- JCO Precision Oncology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1200/po-24-00716
- Citations
- 1
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.82